ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 133 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $196,147 | -32.1% | 7,677 | -23.8% | 0.28% | -15.0% |
| Q2 2023 | $289,008 | -2.9% | 10,077 | -18.8% | 0.33% | -6.1% |
| Q1 2023 | $297,492 | +20.8% | 12,411 | -14.5% | 0.35% | +15.7% |
| Q4 2022 | $246,276 | -20.6% | 14,521 | -30.6% | 0.30% | -11.0% |
| Q3 2022 | $310,000 | -5.8% | 20,916 | +0.2% | 0.34% | +1.5% |
| Q2 2022 | $329,000 | -51.0% | 20,875 | -16.2% | 0.33% | -18.8% |
| Q1 2022 | $672,000 | -40.1% | 24,915 | -17.8% | 0.41% | -18.4% |
| Q4 2021 | $1,122,000 | -58.2% | 30,321 | -46.0% | 0.50% | -48.6% |
| Q3 2021 | $2,683,000 | +55.4% | 56,155 | +10.1% | 0.98% | +71.4% |
| Q2 2021 | $1,726,000 | +67.1% | 51,000 | +104.0% | 0.57% | +42.2% |
| Q1 2021 | $1,033,000 | +56.8% | 25,000 | +64.5% | 0.40% | -19.8% |
| Q4 2020 | $659,000 | – | 15,200 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 208,886 | $5,337,037 | 1.71% |
| Portolan Capital Management | 276,505 | $7,064,703 | 0.66% |
| Nikko Asset Management Americas, Inc. | 1,388,574 | $35,422,523 | 0.42% |
| Green Alpha Advisors, LLC | 21,538 | $550,296 | 0.42% |
| SummerHaven Investment Management, LLC | 22,326 | $570,429 | 0.42% |
| ARK Investment Management | 1,901,546 | $48,584,508 | 0.37% |
| Granahan Investment Management | 398,862 | $10,190,924 | 0.36% |
| FEDERATED HERMES, INC. | 4,711,512 | $120,379,132 | 0.32% |
| Woodline Partners LP | 1,069,814 | $27,333,748 | 0.32% |
| Diametric Capital, LP | 26,130 | $667,621 | 0.28% |